IKOS CIF’s Labcorp LH Stock Holding History

IKOS CIF’s Portfolio LH Stock Details LH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-288	Closed	-$31K	–	273
2015 Q1	$31K	Buy	+288	New	+$29.6K	0.07%	206
2014 Q1	–	Sell	-357	Closed	-$28K	–	265
2013 Q4	$28K	Sell	357 -4,116	-92%	-$351K	0.07%	190
2013 Q3	$381K	Buy	+4,473	New	+$377K	0.46%	75

Other funds holding LH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

DSA

Davis Selected Advisers Tucson, Arizona $21.8B AUM 23.45% 1-Year Est. Return

GCM

Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return

VAM

Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return

IKOS CIF's LH Position: Q2 2015 in Review

IKOS CIF sold out of Labcorp (LH) in Q2 2015, closing a stake of 288 shares — an estimated $31K sold.

IKOS CIF first reported a position in LH in Q3 2013 and held it in 3 quarters. The position peaked at $381K in Q3 2013. 616 funds tracked by Wall St. Rank hold LH as of Q2 2015.

IKOS CIF reported no remaining Labcorp position as of Q2 2015 after selling out during the quarter.
IKOS CIF sold 288 Labcorp shares in Q2 2015, an estimated $31K.
IKOS CIF first reported a position in Labcorp in Q3 2013 and held it in 3 quarters.
IKOS CIF's Labcorp position peaked at $381K in Q3 2013.
616 funds tracked by Wall St. Rank held Labcorp as of Q2 2015.

Based on IKOS CIF's 13F filing for Q2 2015, filed 23 Jul 2015.